Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017180160) METHODS TO REDUCE EVAPORATION DURING ELEVATED TEMPERATURE
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2017/180160 International Application No.: PCT/US2016/027945
Publication Date: 19.10.2017 International Filing Date: 15.04.2016
IPC:
C12Q 1/68 (2006.01)
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
Q
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1
Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
68
involving nucleic acids
Applicants:
SAKURA FINETEK U.S.A., INC. [US/US]; 1750 West 214th Street Torrance, California 90501, US
Inventors:
YAMANISHI, Douglas T.; US
HOM, Clifford; US
SHAH, Amit D.; US
Agent:
BABBITT, William Thomas; US
Priority Data:
Title (EN) METHODS TO REDUCE EVAPORATION DURING ELEVATED TEMPERATURE
(FR) PROCÉDÉS DE RÉDUCTION DE L'ÉVAPORATION EN CAS DE TEMPÉRATURES ÉLEVÉES
Abstract:
(EN) A method including contacting a tissue or cellular sample with a reagent including an evaporation reducing agent(s) having the general formula X1 - R - X2, wherein R is an alkyl, alkenyl, alkynyl or an aromatic moiety of 1 or more carbon atoms that may be substituted with an oxygen, nitrogen or sulfur and X1 and X2 are independently selected to be moiety that is susceptible to hydrogen bonding and processing the tissue or cellular sample. A reagent used in the processing of a tissue or cellular sample with the reagent containing an evaporation reducing agent.
(FR) L'invention concerne un procédé comprenant la mise en contact d'un échantillon tissulaire ou cellulaire avec un réactif comprenant un ou des agents limitant l'évaporation de formule générale X1-R-X2, dans laquelle R est un alkyle, un alcényle, un alcynyle ou une fraction aromatique comportant au moins 1 atome de carbone qui peut être substitué par un atome d'oxygène, d'azote ou de soufre et X1 et X2 sont indépendamment choisis parmi des fractions susceptibles de se lier par liaison hydrogène ; puis le traitement de l'échantillon tissulaire ou cellulaire. L'invention concerne également un réactif utilisé dans le traitement d'un échantillon tissulaire ou cellulaire, le réactif contenant un agent limitant l'évaporation.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)